System and method for breaking reentry circuits by cooling cardiac tissue

• US 7,203,537 B2
• Filed: 01/10/2004
• Issued: 04/10/2007
• Est. Priority Date: 08/19/1996
• Status: Expired due to Fees

• Current Assignee: MR3 Medical, LLC
• Original Assignee: MR3 Medical, LLC
• Inventors: Mower, Morton M.
• Primary Examiner(s): Getzow; Scott M.
• Application Number:
  US10/754,887
• Publication Number:
  US 20040167581A1
• Time in Patent Office: 1,186 Days
• Field of Search: 607/3, 607/14
• US Class Current: 607/3
• CPC Class Codes: A61B 2017/00044 Sensing electrocardiography, i.e. ECG
• CPC Class Codes: A61F 2007/0056 for cooling
• CPC Class Codes: A61F 2007/0075 using a Peltier element, e.g. near the spot to be heated or cooled
• CPC Class Codes: A61F 2007/0095 with a temperature indicator
• CPC Class Codes: A61F 2007/126 for invasive application, e.g. for introducing into blood vessels
• CPC Class Codes: A61F 7/12 Devices for heating or cooling internal body cavities
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3624 occurring in the atrium, i.e. atrial tachycardia

Abstract

Systems and methods to inhibit the conduction of certain spurious electrical impulses in the heart. Inhibition of spurious electrical impulses in the heart is accomplished by cooling one or more targeted portions of the heart. Optionally, inhibition of spurious electrical impulses may be accomplished by cooling of cardiac tissue in combination with pacing of the heart.

Claims

1. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

sensing the onset of arrhythmia;

determining a start temperature of the cardiac tissue at the time of onset of arrhythmia; and

applying a temperature decrease to the cardiac tissue via a cooling means, the cooling means selected from the group consisting of;

applying a cooling fluid to the cardiac tissue, electrically cooling the cardiac tissue, mechanically cooling the cardiac tissue, and chemically cooling the cardiac tissue using an endothermic chemical reaction;

wherein the conduction of spurious electrical impulses in the cardiac tissue are inhibited.

2. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 1 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

3. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

sensing the onset of arrhythmia;

determining a start temperature of the cardiac tissue at the time of onset of arrhythmia;

applying a temperature decrease to the cardiac tissue; and

applying a pacing pulse to the cardiac tissue, wherein the conduction of spurious electrical impulses in the cardiac tissue are inhibited.

4. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 3, wherein applying a pacing pulse to the heart comprises:

planting an electrode in contact with cardiac tissue; and

applying the pacing pulse to the cardiac tissue via the electrode.

5. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 4, wherein the pacing pulse is a cathodal electrical waveform.

6. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 4, wherein the pacing pulse is a biphasic electrical waveform.

7. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 3, wherein applying a pacing pulse to the heart comprises:

locating an electrode in a cardiac blood pool; and

applying the pacing pulse to the cardiac blood pool via the electrode.

8. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 7, wherein the pacing pulse is a cathodal electrical waveform.

9. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 7, wherein the pacing pulse is a biphasic electrical waveform.

10. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 3 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

11. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

detecting a symptom associated with an arrhythmia;

determining a start temperature of the cardiac tissue at the time the symptom is detected;

targeting a portion of the heart affected by a reentry circuit; and

in response to detection of the symptom, transferring heat away from the targeted portion of the heart by absorbing heat into a Peltier cooler located at the targeted portion.

12. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 11, wherein the Peltier cooler is electrically connected to a power source implanted in the patient'"'"'s torso.

13. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 11, wherein the targeted portion is selected from the group consisting of a right anterior-lateral atrial surface, a left anterior-lateral atrial surface, a right postero-lateral a,trial surfaces, and a left postero-lateral atrial surface.

14. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

detecting a symptom associated with an arrhythmia;

determining a start temperature of the cardiac tissue at the time the symptom is detected;

targeting a portion of the heart affected by a reentry circuit; and

in response to detection of the symptom, transferring heat away from the targeted portion in the heart by absorbing heat into heat sink located at the targeted portion and thermally coupled to a Peltier cooler enclosed in a housing that is implanted in the patient'"'"'s torso.

15. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 14, wherein the Peltier cooler is electrically connected to a power source located within the housing.

16. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 14, wherein the heat sink is coupled to the Peltier cooler though mechanical contact.

17. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 14, wherein the heat sink is coupled to the Peltier cooler through a thermal transfer fluid.

18. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 14, wherein the targeted portion is selected from the group consisting of a right anterior-lateral atrial surface, a left anterior-lateral atrial surface, a right postero-lateral atrial surfaces, and a left postero-lateral atrial surface.

19. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

detecting a symptom associated with an arrhythmia;

determining a start temperature of the cardiac tissue at the time the symptom is detected;

targeting a portion of the heart affected by a reentry circuit;

in response to detection of the symptom, transferring heat away from the targeted portion in the bean by absorbing heat into a heat-transfer operator located at the targeted portion; and

applying a pacing pulse to cardiac tissue.

20. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 19, wherein applying a pacing pulse to the heart comprises:

planting an electrode in contact with cardiac tissue; and

applying the pacing pulse to the cardiac tissue via the electrode.

21. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 20, wherein the pacing pulse is a cathodal electrical waveform.

22. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 20, wherein the pacing pulse is a biphasic electrical waveform.

23. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 19, wherein applying a pacing pulse to the heart comprises:

locating an electrode in a cardiac blood pool; and

applying the pacing pulse to the cardiac blood pool via the electrode.

24. The method for inhibiting the conduction of electrical impulses in cardiac tissue of claim 23, wherein the pacing pulse is a cathodal electrical waveform.

25. The method for inhibiting, the conduction of electrical impulses in cardiac tissue of claim 24, wherein the pacing pulse is a biphasic electrical waveform.

26. A method for suppressing arrhythmia in a patient comprising:

implanting a heat-transfer operator in contact with a targeted portion of the patient'"'"'s heart;

suppressing the arrhythmia by operating a heat-transfer operator implanted at the targeted portion to cool the targeted portion of the heart;

wherein implanting a heat-transfer operator in contact with the targeted portion of the patient'"'"'s heart comprises implanting a Peltier cooler on the targeted portion,

wherein the targeted portion is selected from the group consisting of a right anterior-lateral atrial surface, a left anterior-lateral atrial surface, a right postero-lateral atrial surfaces, and a left postero-lateral atrial surface; and

applying a biphasic pulse to cardiac tissue, wherein the biphasic pulse comprises;

a first stimulation phase with a first phase polarity, a first phase amplitude,

a first phase shape and a first phase duration;

a second stimulation phase with a polarity opposite to the first phase polarity, a second phase amplitude that is larger in absolute value than the first phase amplitude, a second phase shape and a second phase duration,

wherein the first stimulation phase and the second stimulation phase are applied in sequence to cardiac tissue.

27. The method for suppressing arrhythmia in a patient of claim 26, wherein the Peltier cooler is electrically connected to a power source implanted in the patient'"'"'s torso.

28. The method for suppressing arrhythmia in a patient of claim 26 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

33. The method for suppressing arrhythmia in a patient of claim 26, wherein the method further comprises detecting a symptom associated with an arrhythmia.

34. The method for suppressing arrhythmia in a patient of claim 33, wherein detecting a symptom associated with the arrhythmia comprises detecting a symptom selected from the group consisting of a change in a measure of heart function and an electrical change within the heart.

29. A method for suppressing arrhythmia in a patient comprising:

implanting a heat-transfer operator in contact with a targeted portion of the patient'"'"'s heart;

suppressing the arrhythmia by operating a heat-transfer operator implanted at the targeted portion to cool the targeted portion of the heart;

implanting a heat sink on the targeted portion , wherein the targeted portion is selected from the group consisting of a right anterior-lateral atrial surface, a left anterior-lateral atrial surface, a right postero-lateral atrial surfaces, and a left postero-lateral atrial surface;

thermally coupling the heat sink implanted on the targeted portion to a Peltier cooler enclosed in a housing that is implanted in the patient'"'"'s torso; and

applying a biphasic pacing pulse to cardiac tissue, wherein the biphasic pulse comprises;

a first stimulation phase with a first phase polarity, a first phase amplitude,

a first phase shape and a first phase duration;

a second stimulation phase with a polarity opposite to the first phase polarity, a second phase amplitude that is larger in absolute value than the first phase amplitude, a second phase shape and a second phase duration,

wherein the first stimulation phase and the second stimulation phase are applied in sequence to the cardiac tissue.

30. The method for suppressing arrhythmia in a patient of claim 29, wherein the Peltier cooler is electrically connected to a power source located within the housing.

31. The method for suppressing arrhythmia in a patient of claim 29, wherein the heat sink is coupled to the Peltier cooler through mechanical contact.

32. The method for suppressing arrhythmia in a patient of claim 29, wherein the heat sink is coupled to the Peltier cooler through a thermal transfer fluid.

35. The method for suppressing arrhythmia in a patient of claim 29 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

36. A method for suppressing arrhythmia in a patient Comprising:

implanting a heat-transfer operator in contact with a targeted portion of the patient'"'"'s heart;

suppressing the arrhythmia by operating a heat-transfer operator implanted at the targeted portion to cool the targeted portion of the heart; and

applying a biphasic pacing pulse to cardiac tissue, wherein the biphasic pulse comprises;

a first stimulation phase with a first phase polarity, a first phase amplitude,

a first phase shape and a first phase duration;

a second stimulation phase with a polarity opposite to the first phase polarity, a second phase amplitude that is larger in absolute value than the first phase amplitude, a second phase shape and a second phase duration,

wherein the first stimulation phase and the second stimulation phase are applied in sequence to cardiac tissue.

37. The method for suppressing arrhythmia in a patient of claim 36, wherein applying a pacing pulse to the heart comprises:

planting an electrode in contact with cardiac tissue; and

applying the biphasic pacing pulse to the cardiac tissue via the electrode.

38. The method for suppressing arrhythmia in a patient of claim 37, wherein the first phase polarity is positive.

39. The method for suppressing arrhythmia in a patient of claim 37, wherein the first phase amplitude is ramped from a baseline value to a second value.

40. The method for suppressing arrhythmia in a patient of claim 37, wherein applying a pacing pulse to the heart comprises:

locating an electrode in a cardiac blood pool; and

applying the pacing pulse to the cardiac blood pool via the electrode.

41. The method for suppressing arrhythmia in a patient of claim 40, wherein the wherein the first phase polarity is positive.

42. The method for suppressing arrhythmia in a patient of claim 41, wherein the first phase amplitude is ramped from a baseline value to a second value.

43. The method for suppressing arrhythmia in a patient of claim 36 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

44. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

sensing the onset of arrhythmia;

evaluating the sensed arrhythmia;

determining a start temperature of the cardiac tissue at the time of onset of arrhythmia;

based on the evaluation of the sensed arrhythmia and the start temperature, selecting one or more remedial measures from the group consisting of applying a temperature decrease to the cardiac tissue and applying a pacing pulse to the cardiac tissue; and

applying the selected remedial measures.

45. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 44 further comprising:

sensing the cardiac tissue functioning; and

ceasing the application of the selected remedial measures if the cardiac tissue reverts to sinus rhythm.

46. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 44 further comprising:

sensing the cardiac tissue functioning; and

continuing the application of the selected remedial measures if the cardiac tissue has not reverted to sinus rhythm.

47. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 44 further comprising:

sensing the cardiac tissue functioning; and

ceasing the application of the selected remedial measures if the cardiac tissue reverts to sinus rhythm.

48. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 44 further comprising:

sensing the cardiac tissue functioning;

if the cardiac tissue has not returned to sinus rhythm, selecting one or more continuing remedial measures from the group consisting of applying a temperature decrease to the cardiac tissue and applying a pacing pulse to the cardiac tissue; and

applying the selected one or more continuing remedial measures.

49. The method for inhibiting the conduction of spurious electrical impulses in cardiac tissue of claim 44 further comprising:

monitoring a current temperature of the cardiac tissue; and

ceasing the application of the temperature decrease when the current temperature is less than or equal to a desired temperature.

50. An apparatus far inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

a sensing means for sensing the onset of arrhythmia

a means for determining a start temperature of the cardiac tissue at the time of onset of arrhythmia; and

a cooling means responsive to the sensing means for applying a cooling stimulus to the cardiac tissue;

wherein the cooling means is selected from the group consisting of a means for applying a cooling fluid to the cardiac tissue, an electrical cooling apparatus, a mechanical cooling apparatus, and an endothermic chemical reaction.

51. An apparatus for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising;

a sensing means for sensing the onset of arrhythmia;

a means for determining a start temperature of the cardiac tissue at the time of onset of arrhythmia;

a cooling means responsive to the sensing means for applying a cooling stimulus to the cardiac tissue;

a cardiac stimulation generator; and

an electrode in contact with cardiac tissue, wherein the electrode is connected to the cardiac stimulation generator,

wherein the cardiac stimulation generator is adapted to apply a pacing pulse to the cardiac tissue.

52. The apparatus of claim 51, wherein the cardiac Stimulation generator is responsive to the sensing means.

53. The apparatus of claim 52 further comprising:

a cardiac stimulation generator;

an electrode in contact with a cardiac blood pool, wherein the electrode is connected to the cardiac stimulation generator; and

wherein the cardiac stimulation generator is adapted to apply a pacing pulse to the cardiac blood pool.

54. The apparatus of claim 53, wherein the pacing pulse is a cathodal electrical waveform.

55. The apparatus of claim 54, wherein the pacing pulse is a biphasic electrical waveform.

56. The apparatus of claim 51, wherein the pacing pulse is a cathodal electrical waveform.

57. The apparatus of claim 51, wherein the pacing pulse is a biphasic electrical waveform.

58. A method for inhibiting the conduction of spurious electrical impulses in cardiac tissue comprising:

sensing the onset of arrhythmia;

detecting a start temperature of the cardiac tissue at the time of onset of the arrhythmia;

evaluating the sensed arrhythmia;

monitoring a cardiac tissue temperature;

using the evaluation of the sensed arrhythmia and the cardiac tissue temperature to select one or more remedial measures from the group consisting of applying a temperature decrease to the cardiac tissue and applying a pacing pulse to the cardiac tissue; and

applying the selected remedial measures.